cDNA And oDNA Microchips Market By Application (Gene Identification & Detection, Comparative Genomic Hybridization, Gene Expression Profiling, Drug Discovery, Others), By End User (Research Organizations And Institutes, Biotech Companies, Clinical Laboratories) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026
"New technology assessment in the cDNA and oDNA microchips market to exhibit noteworthy growth during the forecast period"
The global cDNA and oDNA microchips market is growing effectively, was valued at US$ 458.2 Mn in 2017 and expected to reach US$ 1,050.3 Mn by 2026. The global market is growing productively at a CAGR of 9.7% during the forecast period. Incorporation of new technologies in the biological and electronic component of microchips is enhancing the overall growth globally. Advancement in nanotechnology, clinical diagnostics, cancer research, and agriculture also reflects favorable growth during the forecast period. High global prevalence of cancer provides major opportunity in the global market. Increasing popularity of cDNA and oDNA microchips has encouraged many international players to enter the marketplace and gain profit from its growing demand on a global scale, especially in countries such as U.S., Germany, Israel, China, India, Singapore, Japan, and South Korea. DNA microarray market in these countries are poised for enormous growth as drug discovery, biotech & cancer research and clinical trials intensify the overall growth on a global scale.
Rising adoption of biochips for personalized medicine, growing applications in cancer, and technological assessments in advanced DNA microarray systems and sensors are the major drivers of the cDNA and oDNA microchips market. Additionally, the advanced technology in gene chips has now become very popular in the medical research sector and drug discovery, as it considerably brings down the overall research time with enhanced and quick results. This particular technology is mainly used to simultaneously quantify expression levels of thousands of genes. However, outsourcing of bio-processing activities of pharmaceutical and biotechnology companies, strict regulations, high instrumentation expenses in the developing markets may hinder the market development to a certain extent during the forecast period.
"Gene expression application is expected to register higher growth by the end of 2026"
In 2017, gene expression and profiling in the application segment held the maximum revenue share. The penetration of this segment is high due to its sophisticated stability, low limits of gene detection and wide response range. The advanced product lines play highly complementary roles in genomics, molecular biology, and life science research.
In addition to genetic applications, DNA microarray is also utilized in toxicological, protein, and biochemical research in developed countries. The manufacturers are expanding the usage with higher technology assessment utilized for top applications such as cancer diagnosis, microbial genotyping, genomics, agricultural biotechnology, drug discovery, single nucleotide polymorphism (SNP) analysis and other applications including environmental biology, screening and monitoring of patient data in clinical trials, proteomics, and toxicogenomics. For example, Toyo Seikan Group Holdings (Japan) developing chips designed for definite applications. They have recently developed a DNA chip for examining fungi. The DNA chip distributes more than 630 species of fungi into 32 groups and can test them instantaneously.
"Research Organizations and Institutes to dominate the market with a significant CAGR"
Growth & development of the cDNA and oDNA microchips in research organizations along with biotech firms will gain traction during the forecast period. cDNA and oDNA microchips are now considered as an important tool for biomarker discovery, cancer research molecular cytogenetics, agricultural biotechnology and genomics. The rise in usage of genome testing is generating significant revenue share globally. A notable growth in the drug discovery applications, gene identification & detection show promising opportunities in the near future.
Additionally, administrations of cDNA and oDNA microchips as biochips, lab on chip, clinical proteomics and advanced usage for cancer diagnostics show significant growth in the market. The global market is largely driven by development in personalized medicine, need for early cancer detection and government or private funding in developing nations for advanced research.
"Increasing applications along with swift new technology launch, and presence of top players holds North America in dominant position"
Presently, the U.S generated maximum market share in the global cDNA and oDNA microchips market attributed to the increasing adoption of DNA microarrays and progression in the field of biotechnology, microelectronics, and nanotechnology. The North America cDNA and oDNA microchips market is driven by the applications in drug discovery & development, higher preference for compact DNA microarrays, shift towards the use of live model systems for gene identification and evaluation, and growing demand for advanced research in cancer and diagnostics industry.
Key factors funding to the overall growth include rising R&D in the gene expression profiling segment, increasing adoption of personalized medicine and the development of miniaturized analytical equipment or chips on a global scale. Additionally, it is projected that the biochips market in the Asia Pacific and Europe will witness rapid growth in the given period of forecast. The increase in biopharmaceutical companies from the Asia Pacific, especially in countries such as China, South Korea, and India coupled with the recent trend of outsourcing of research processes to Asian countries for various genome applications would drive the market.
"Presence of multinational manufacturers with strong technology portfolio in the developed regions"
Top manufacturers in the cDNA and oDNA microchips market are Sequenom, Inc., GE Healthcare, Thermo Fisher Scientific, Roche Nimblegen, Biometrix Technology, Cepheid, Agilent Technologies, Inc., Applied Microarrays, Inc., DNA Chip Research, Inc., DNAmicroarray, Inc., Greiner Bio-One GmbH, Illumina, Inc., Scienion AG, Life Technologies Corporation, Toray International UK Ltd., Affymetrix, Inc., and others.
Major corporations are implementing advanced approaches along with new technology assessments in new DNA microarray models in drug discovery, medical diagnostics, and advance biotech research. For instance, in June 2017, CellChipGroup at the Vienna University of Technology developed the miniaturized wound healing system (a chip for wound healing measurement). Additionally, in September 2017, GSI Lumonics, Inc. and NEN Life Science Products signed an agreement to jointly market laser scanner systems and DNA microarray systems globally.
Historical & Forecast Period
This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026.
Key questions answered in this report
- What are the current market trends and dynamics in the cDNA and oDNA microchips market and valuable opportunities for emerging players?
- What are the current dynamics in the DNA microchips market and valuable opportunities for emerging players?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which application type holds prominent market share and why?
- What is the impact of high cost of DNA microarray processes in the developing markets?
- What are the products and brands in the DNA microchip industry that are growing more significantly and why?
- What are the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global cDNA and oDNA Microchips Market Portraiture
2.2. Global cDNA and oDNA Microchips Market, by Application, 2017 (US$ Mn)
2.3. Global cDNA and oDNA Microchips Market, by End User, 2017 (US$ Mn)
2.4. Global cDNA and oDNA Microchips Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global cDNA and oDNA Microchips Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Current Scenario: New Product Launches, Increasing End Users in Medical Diagnostics, Drug Discovery
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global cDNA and oDNA Microchips Market, by Application, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Gene Identification & Detection
4.3. Comparative Genomic Hybridization
4.4. Gene Expression Profiling
4.5. Drug Discovery
4.6. Others (Re-sequencing/Genomics, Molecular Cytogenetics, Proteomics, Agricultural Biotechnology)
Chapter 5. cDNA Global & oDNA Microchips Market, by End User, 2016 – 2026 (US$)
5.1. Overview
5.2. Research Organizations and Institutes
5.3. Biotech Companies
5.4. Clinical Laboratories
Chapter 6. Global cDNA and oDNA Microchips Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America cDNA and oDNA Microchips Market Analysis, 2016 – 2026
6.2.1. North America cDNA and oDNA Microchips Market, by Application, 2016 – 2026 (US$ Mn)
6.2.2. North America cDNA and oDNA Microchips Market, by End User, 2016 – 2026 (US$ Mn)
6.2.3. North America cDNA and oDNA Microchips Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe cDNA and oDNA Microchips Market Analysis, 2016 – 2026
6.3.1. Europe cDNA and oDNA Microchips Market, by Application, 2016 – 2026 (US$ Mn)
6.3.2. Europe cDNA and oDNA Microchips Market, by End User, 2016 – 2026 (US$ Mn)
6.3.3. Europe cDNA and oDNA Microchips Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific cDNA and oDNA Microchips Market Analysis, 2016 – 2026
6.4.1. Asia Pacific cDNA and oDNA Microchips Market, by Application, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific cDNA and oDNA Microchips Market, by End User, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific cDNA and oDNA Microchips Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America cDNA and oDNA Microchips Market Analysis, 2016 – 2026
6.5.1. Latin America cDNA and oDNA Microchips Market, by Application, 2016 – 2026 (US$ Mn)
6.5.2. Latin America cDNA and oDNA Microchips Market, by End User, 2016 – 2026 (US$ Mn)
6.5.3. Latin America cDNA and oDNA Microchips Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) cDNA and oDNA Microchips Market Analysis, 2016 – 2026
6.6.1. MEA cDNA and oDNA Microchips Market, by Application, 2016 – 2026 (US$ Mn)
6.6.2. MEA cDNA and oDNA Microchips Market, by End User, 2016 – 2026 (US$ Mn)
6.6.3. MEA cDNA and oDNA Microchips Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Illumina, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Sequenom, Inc.
7.3. GE Healthcare
7.4. Thermo Fisher Scientific
7.5. Roche Nimblegen
7.6. Biometrix Technology
7.7. Cepheid
7.8. Agilent Technologies, Inc.
7.9. Applied Microarrays, Inc.
7.10. DNA Chip Research, Inc.
7.11. DNAmicroarray, Inc.
7.12. Greiner Bio-One GmbH
7.13. Scienion AG
7.14. Life Technologies Corporation
7.15. Toray International UK Ltd.
7.16. Affymetrix, Inc.
TABLE 1 Market Snapshot: Global cDNA and oDNA Microchips Market
TABLE 2 Global cDNA and oDNA Microchips Market, by Application, 2016–2026 (US$ Mn)
TABLE 3 Global cDNA and oDNA Microchips Market, by End User, 2016–2026 (US$ Mn)
TABLE 4 Global cDNA and oDNA Microchips Market, by Geography, 2016–2026 (US$ Mn)
TABLE 5 North America cDNA and oDNA Microchips Market, by Application, 2016–2026 (US$ Mn)
TABLE 6 North America cDNA and oDNA Microchips Market, by End User, 2016–2026 (US$ Mn)
TABLE 7 North America cDNA and oDNA Microchips Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe cDNA and oDNA Microchips Market, by Application, 2016–2026 (US$ Mn)
TABLE 9 Europe cDNA and oDNA Microchips Market, by End User, 2016–2026 (US$ Mn)
TABLE 10 Europe cDNA and oDNA Microchips Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 11 Latin America cDNA and oDNA Microchips Market, by Application, 2016–2026 (US$ Mn)
TABLE 12 Latin America cDNA and oDNA Microchips Market, by End User, 2016–2026 (US$ Mn)
TABLE 13 Latin America cDNA and oDNA Microchips Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Asia Pacific cDNA and oDNA Microchips Market, by Application, 2016–2026 (US$ Mn)
TABLE 15 Asia Pacific cDNA and oDNA Microchips Market, by End User, 2016–2026 (US$ Mn)
TABLE 16 Asia Pacific cDNA and oDNA Microchips Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 17 Middle East & Africa cDNA and oDNA Microchips Market, by Application, 2016–2026 (US$ Mn)
TABLE 18 Middle East & Africa cDNA and oDNA Microchips Market, by End User, 2016–2026 (US$ Mn)
TABLE 19 Middle East & Africa cDNA and oDNA Microchips Market, by Region, 2016–2026 (US$ Mn)
TABLE 20 Illumina, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Sequenom, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 GE Healthcare: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Thermo Fisher Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Roche Nimblegen: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Biometrix Technology: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Cepheid: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Agilent Technologies, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Applied Microarrays, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 DNA Chip Research, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 DNAmicroarray, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Greiner Bio-One GmbH: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Scienion AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Life Technologies Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Toray International UK Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Affymetrix, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
FIG. 1 Global cDNA and oDNA Microchips Market: Research Methodology
FIG. 2 Global cDNA and oDNA Microchips Market Segmentation
FIG. 3 Global cDNA and oDNA Microchips Market, by Application, 2017 (US$ Mn)
FIG. 4 Global cDNA and oDNA Microchips Market, by End User, 2017 (US$ Mn)
FIG. 5 Global cDNA and oDNA Microchips Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition, by Geography, 2017
FIG. 7 Market Positioning of Key cDNA and oDNA Microchips Manufacturers, 2017
FIG. 8 Global cDNA and oDNA Microchips Market for Gene Identification & Detection, 2016–2026 (US$ Mn)
FIG. 9 Global cDNA and oDNA Microchips Market for Comparative Genomic Hybridization, 2016–2026 (US$ Mn)
FIG. 10 Global cDNA and oDNA Microchips Marketfor Gene Ecpression Profiling, 2016–2026 (US$ Mn)
FIG. 11 Global cDNA and oDNA Microchips Marketfor Drug Discovery, 2016–2026 (US$ Mn)
FIG. 12 Global cDNA and oDNA Microchips Marketfor Other Apllications (Re-sequencing/Genomics, Molecular Cytogenetics, Proteomics, Agricultural Biotechnology), 2016–2026 (US$ Mn)
FIG. 13 Global cDNA and oDNA Microchips Market in Research Oraganizations and Institutes, 2016–2026 (US$ Mn)
FIG. 14 Global cDNA and oDNA Microchips Market in Biotech Companies, 2016–2026 (US$ Mn)
FIG. 15 Global cDNA and oDNA Microchips Market in Clinical Laboratories, 2016–2026 (US$ Mn)
FIG. 16 U.S. cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 17 Canada cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 18 U.K. cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 19 Germany cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 20 Rest of Europe cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 21 Japan cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 22 China cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 23 Rest of Asia Pacific cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 24 Brazil cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 25 Mexico cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 26 Rest of Latin America cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 27 GCC cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
FIG. 28 Rest of Middle East & Africa cDNA and oDNA Microchips Market, 2016–2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)